Yi-Hsiang Huang Selected Research

Renal Insufficiency (Renal Failure)

11/2023	Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
4/2020	Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade.
1/2015	Impact of renal insufficiency on patients with hepatocellular carcinoma undergoing radiofrequency ablation.
9/2010	Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
2/2010	Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Hsiang Huang Research Topics

Disease

129	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 03/2002
86	Neoplasms (Cancer) 04/2024 - 10/2004
66	Fibrosis (Cirrhosis) 04/2024 - 07/2006
30	Chronic Hepatitis C 04/2024 - 03/2014
27	Liver Neoplasms (Liver Cancer) 04/2024 - 05/2005
26	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 07/2006
20	Infections 06/2023 - 05/2007
20	Ascites 01/2023 - 03/2004
19	Liver Diseases (Liver Disease) 01/2024 - 11/2002
18	Chronic Hepatitis B 01/2024 - 06/2010
17	Hepatitis B 03/2023 - 06/2007
16	End Stage Liver Disease 10/2023 - 12/2004
16	Inflammation (Inflammations) 10/2022 - 10/2011
14	Portal Hypertension 01/2023 - 03/2015
11	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2009
10	Disease Progression 11/2023 - 12/2004
10	Hepatitis 04/2021 - 11/2002
8	Hepatitis C 01/2024 - 03/2014
8	Fatty Liver 10/2022 - 01/2013
7	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2016
7	Hepatic Encephalopathy 10/2022 - 07/2011
6	Chronic Renal Insufficiency 01/2022 - 03/2004
5	Hemorrhage 12/2023 - 09/2010
5	Renal Insufficiency (Renal Failure) 11/2023 - 02/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2023 - 03/2015
5	Liver Failure 08/2021 - 07/2011
4	Diabetes Mellitus 04/2024 - 01/2018
4	Obesity 10/2023 - 10/2011
4	Fatigue 08/2023 - 01/2017
4	Virus Diseases (Viral Diseases) 03/2023 - 01/2019
4	Sepsis (Septicemia) 01/2022 - 01/2020
4	Rheumatoid Arthritis 11/2021 - 01/2017
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2010
4	Chronic Hepatitis D 04/2009 - 03/2005
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2020
3	COVID-19 11/2023 - 01/2023
3	Overweight 10/2023 - 10/2011
3	Thrombosis (Thrombus) 08/2023 - 01/2022
3	Chronic Hepatitis (Chronic Active Hepatitis) 03/2023 - 01/2017
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2022 - 01/2008

Drug/Important Bio-Agent (IBA)

40	Antiviral Agents (Antivirals)IBA 04/2024 - 03/2010
40	BilirubinIBA 01/2024 - 02/2010
36	AlbuminsIBA 01/2024 - 12/2011
25	Fetal Proteins (Fetoprotein)IBA 11/2023 - 05/2011
23	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2022 - 06/2007
22	InterferonsIBA 01/2024 - 03/2014
20	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2024 - 02/2004
15	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2020
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2010
14	Cytidine Triphosphate (CTP)IBA 10/2023 - 12/2004
13	Alanine Transaminase (SGPT)IBA 01/2023 - 04/2005
13	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 03/2015
12	Hepatitis B e AntigensIBA 01/2024 - 03/2010
11	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2023 - 10/2009
10	entecavir FDA Link 01/2024 - 03/2010
10	CreatinineIBA 03/2023 - 03/2004
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2008
10	Serum AlbuminIBA 12/2018 - 10/2004
9	CytokinesIBA 02/2024 - 11/2014
8	SofosbuvirIBA 01/2024 - 12/2018
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2013
8	Ribavirin (Virazole)FDA LinkGeneric 10/2021 - 01/2017
7	Tenofovir (Viread)FDA Link 01/2024 - 11/2018
7	SodiumIBA 10/2022 - 09/2009
7	Rituximab (Mabthera)FDA Link 11/2021 - 03/2010
6	NivolumabIBA 10/2022 - 01/2020
6	Alkaline PhosphataseIBA 12/2021 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2013
5	Bevacizumab (Avastin)FDA Link 08/2023 - 10/2022
5	atezolizumabIBA 08/2023 - 10/2022
5	daclatasvirIBA 01/2021 - 12/2018
5	AntigensIBA 10/2020 - 06/2010
4	glecaprevir and pibrentasvirIBA 04/2024 - 12/2018
4	regorafenibIBA 04/2022 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 02/2020
4	Thioacetamide (Thioacetamid)IBA 01/2021 - 11/2014
4	Proton Pump InhibitorsIBA 12/2020 - 01/2017
4	Surface Antigens (Surface Antigen)IBA 01/2020 - 08/2015
4	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2008
3	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 10/2019
3	CholesterolIBA 04/2024 - 01/2013
3	velpatasvirIBA 01/2024 - 12/2018
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 06/2019
3	Propranolol (Inderal)FDA LinkGeneric 12/2023 - 01/2020
3	lenvatinibIBA 11/2022 - 01/2022
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 01/2018
3	LipidsIBA 01/2022 - 01/2017

Therapy/Procedure

80	Therapeutics 04/2024 - 11/2002
20	Radiofrequency Ablation 09/2022 - 01/2008
12	Immunotherapy 02/2024 - 01/2020
12	Drug Therapy (Chemotherapy) 09/2022 - 05/2009
12	Surgical Instruments (Clip) 04/2021 - 10/2004
11	Ligation 12/2023 - 11/2014
7	Liver Transplantation 09/2022 - 12/2004
5	Transplantation 12/2021 - 01/2012
4	Aftercare (After-Treatment) 01/2024 - 08/2006
4	Fecal Microbiota Transplantation 11/2023 - 12/2021
4	Stents 01/2022 - 10/2019
3	Contraindications 01/2022 - 01/2017